Re: Aging & Longevity News and Discussions
Posted: Wed Oct 25, 2023 9:25 pm
Will Turn Bio be the first longevity company to take cell rejuvenation to the clinic?
Author: LT Staff | Published on: October 25, 2023
https://longevity.technology/news/will- ... he-clinic/
Author: LT Staff | Published on: October 25, 2023
Cell rejuvenation company Turn Biotechnologies has reported receiving positive feedback during an FDA INTERACT meeting to review the company’s therapeutic treatment to rejuvenate skin cells. The company, which is developing mRNA medicines for a range of age-related conditions, said that the meeting focused on its progress and plans for TRN-001, a treatment designed to repair damaged skin at the cellular level.
Turn Bio says its preclinical results demonstrate that TRN-001 improves skin integrity, reduces inflammation and cell senescence and achieves hair follicle transfection. If the therapy goes on to work in humans, the company claims it would be the first treatment to repair skin damage at a cellular level, restoring follicles’ ability to grow hair.
https://longevity.technology/news/will- ... he-clinic/